Unichem Laboratories Limited (NSE:UNICHEMLAB)
India · Delayed Price · Currency is INR 298.30
+0.10 (0.03%)
Apr 2, 2026, 3:28 PM IST
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 21.01 billion as of April 2, 2026. Its market cap has decreased by -55.60% in one year.
Market Cap
21.01B
Enterprise Value
24.10B
Revenue
22.14B
Ranking
n/a
PE Ratio
7.13
Stock Price
298.30
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 21.01B, an increase of 261.84%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 21.01B | -32.38% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 40.31B |
| Sun Pharma Advanced Research Company | 40.26B |
| RPG Life Sciences | 31.05B |
| Orchid Pharma | 26.34B |
| Solara Active Pharma Sciences | 22.12B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |
| Beta Drugs | 12.82B |